GlassScriptPhysician profile
Robert Mark Klinestiver
NPI 1851383012
$12,983.94
in general payments reported to CMS, 2019-2025
50 companies · $4,519 in 2025
The $4,519 reported for 2025 was more than what 87% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,402 · 2020: $273 · 2021: $916 · 2022: $1,262 · 2023: $2,171 · 2024: $2,441 · 2025: $4,519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,663 · Travel and Lodging: $1,289 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,662.72 |
| Travel and Lodging | $1,289.08 |
| Education | $178.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,753.85 | 2019-2025 | Tezspire, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $1,276.66 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Intuitive Surgical, INC. | $900.47 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $806.30 | 2022-2025 | Dupixent |
| Grifols USA, LLC | $766.53 | 2019-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $654.57 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $577.23 | 2019-2025 | Stiolto Respimat, Ofev |
| Amgen INC. | $530.56 | 2019-2025 | Tezspire, Prolia, Evenity |
| Takeda Pharmaceuticals U.S.A., INC. | $478.44 | 2019-2025 | Glassia, Trintellix |
| Olympus Corporation of The Americas | $449.87 | 2025 | |
| Mylan Specialty L.P. | $410.44 | 2019-2024 | Yupelri |
| Verona Pharma, INC. | $363.95 | 2025 | Ohtuvayre |
| Insmed, INC. | $283.39 | 2019-2025 | Arikayce, Brinsupri |
| Abbvie INC. | $283.08 | 2019-2024 | |
| Philips North America LLC | $282.15 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $258.54 | 2021-2025 | Acthar |
| Novo Nordisk INC | $226.85 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Viatris Specialty LLC | $204.70 | 2025 | Yupelri |
| Baxter Healthcare | $181.61 | 2025 | Hillrom - Monarch Airway Clearance System |
| Exact Sciences Corporation | $148.41 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $137.88 | 2019-2024 | |
| Abbott Laboratories | $108.05 | 2020-2024 | Freestyle Libre 3 |
| Mallinckrodt Enterprises LLC | $80.26 | 2019 | |
| Sanofi-Aventis U.S. LLC | $78.99 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $71.14 | 2019-2021 | |
| Amarin Pharma, INC. | $54.89 | 2019-2020 | |
| Shire North American Group INC | $47.79 | 2019 | |
| Novartis Pharmaceuticals Corporation | $43.14 | 2019 | |
| Janssen Pharmaceuticals, INC | $41.68 | 2019-2022 | |
| Circassia INC. | $40.52 | 2019 | |
| Alexion Pharmaceuticals, INC. | $34.40 | 2021-2025 | Ultomiris |
| Antares Pharma, INC. | $33.46 | 2022-2023 | Nocdurna, Xyosted, Tlando |
| Pulmonx Corporation | $32.78 | 2022-2024 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Gilead Sciences, INC. | $29.77 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $29.68 | 2025 | Jynarque |
| Merck Sharp & Dohme LLC | $29.59 | 2019-2023 | Dificid |
| Idorsia Pharmaceuticals US INC | $28.07 | 2022-2023 | Quviviq |
| Melinta Therapeutics, LLC | $25.80 | 2024 | Rezzayo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.71 | 2019-2023 | Xifaxan |
| Dexcom, INC. | $24.46 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.08 | 2023 | |
| Rgh Enterprises LLC | $20.05 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.44 | 2022 | |
| Paratek Pharmaceuticals, INC. | $14.76 | 2020 | |
| Seqirus USA INC | $14.03 | 2022 | |
| Sanofi Pasteur INC. | $13.22 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.14 | 2022 | |
| Medtronic, INC. | $12.96 | 2023 | Intellis Adaptivestim |
| Vertiflex, INC. | $11.62 | 2019 | |
| Lilly USA, LLC | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Klinestiver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.